Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
감염 및 예방 접종 후 이종 SARS-CoV-2-중화 활동
Article
[키워드] activity
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
analyzed
antibody
Antibody Response
Antibody responses
best
Beta
Cohort
coronavirus
COVID-19
COVID-19 vaccination
D614G
declined
decrease
Delta
dose
exceeded
greater
heterogeneity
Hospitalized
hospitalized patient
hospitalized patients
Humoral immunity
Immunity
Improvements
individual
infected individual
infected individuals
infecting
Infection
lowest
mRNA vaccine
Mutation
N-terminal domain
neutralization
neutralization titer
neutralizing activities
Neutralizing activity
Neutralizing antibodies
neutralizing antibody responses
no difference
not differ
pandemic
Patient
patients
Protein
recognize
respiratory
SARS-CoV-2
SARS-CoV-2 spike
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2-neutralizing antibodies
SARS-CoV-2-specific antibody responses
SARS-CoV-2-specific neutralizing antibodies
second vaccination
sequence
serum sample
serum samples
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
significantly
significantly lower
Specific
specific neutralizing antibodies
Spike protein
symptom onset
the SARS-CoV-2
the spike protein
vaccinated individual
vaccinated individuals
Vaccine
vaccinee
vaccinees
variants
variants of concern
viral strain
viral strains
virus infection
VoC
VOCs
[DOI] 10.3389/fimmu.2022.888794 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.888794 PMC 바로가기 [Article Type] Article